Posts Tagged ‘ICPH’
Why Inova is getting into the drug discovery business, Washington Business Journal, December 13, 2016
Inova’s drug discovery program is yet another component of the hospital’s broader ambitions to create a nationally recognized precision medicine and cancer care center. Read more.
Read MoreInova recruits managers for $100 million venture-capital program, Modern Healthcare, December 13, 2016
Inova Health System will provide $100 million in venture capital over the next three to five years to support precision-medicine companies and create an incubator for startups. The goal is develop ideas to improve the broader health system and make money off the innovations. Read more.
Read MoreInova Health Launches Investment Arm and Accelerator in Falls Church, Potomac Tech Wire, December 13, 2016
Inova Health System has tapped a pair of local heavyweights to serve as managing directors of its newly launched investment arm and accelerator. Read more.
Read MoreInova Health System and the University of Virginia Plan Comprehensive Research and Education Partnership
Inova and the University of Virginia Plan Comprehensive Research and Education Partnership to Accelerate Joint Discovery, Application of Medical Research, and Commercialization of New Discoveries Partnership will include joint recruitment of eminent scientists to the Commonwealth of Virginia Falls Church, Va., November 02, 2016 – Inova Health System and the University of Virginia announced today…
Read MoreInova Leaders in Gynecologic Cancer and Proteomic Research to Spearhead Cancer Moonshot’s APOLLO Program
APOLLO will accelerate the understanding and application of proteogenomics in cancer treatment FALLS CHURCH, VA – October 17, 2016 – Earlier today, Vice President Joe Biden and Dr. Jill Biden announced updates related to the federal Moonshot for Cancer program, which aims to make a decade’s worth of progress in the fight against cancer in…
Read MoreInova Names Michael Maitland, M.D, Ph.D., Director of Therapeutics for the Inova Center for Personalized Health
Maitland will also serve as Associate Director of Cancer Therapeutics for the Inova Schar Cancer FALLS CHURCH, VA – August 16, 2016 – Inova Health System is pleased to welcome Michael Maitland, M.D., Ph.D., where he will serve as the new Director of Therapeutics for the Inova Center for Personalized Health (ICPH) and as Associate Director…
Read MoreInova Schar Cancer Institute Announces Formation of First Molecular Tumor Board in the Metro D.C. Area Where Patients and Their Families Participate
The Inova molecular tumor board aims to provide patients and their physicians access, information, education and advocacy FALLS CHURCH, VA – April 12, 2016 – The Inova Schar Cancer Institute announced today the formation of a molecular tumor board (MTB) comprised of physicians, oncologists, researchers, and genetic counselors. These experts convene weekly to analyze advanced and…
Read MoreInova Embraces Obama Administration “Moonshot” to Cure Cancer Initiative by Naming Thomas P. Conrads, PhD, to Cancer Research Team
FALLS CHURCH, VA – January 21, 2016 – At last week’s State of the Union address, President Obama brought renewed resolve to the fight to cure cancer, acknowledging that the scientific community is on the brink of significant break-throughs. He called for additional research, more funding, and collaboration among health systems, academic research institutions, private industry,…
Read MoreDavid Bowie and Liver Cancer: Bringing Awareness to the Disease and Promising New Treatments on the Horizon
Timothy L. Cannon, MD, is board certified in medical oncology, hematology and internal medicine. His specialty is managing gastrointestinal cancers. Dr. Cannon emphasizes personalized care for his patients and is interested in pharmacogenomics as well as using technology to improve patients’ access to care. Read Dr. Cannon’s profile. Entertainment legend David Bowie’s death from liver…
Read MoreHow complicated is precision medicine? Inova-GMU proteomics partnership gives us a glimpse, Washington Business Journal, December 21, 2015
When Virginia Gov. Terry McAuliffe announced Inova Health System and George Mason University will partner on precision medicine, he revealed a major component of the deal would include $1 million toward a new joint center for studying proteomics. Read more. TweetPinShare0 Shares
Read More